Curative surgery after neoadjuvant chemotherapy in metastatic poorly differentiated neuroendocrine carcinoma

Eur J Surg Oncol. 2007 Dec;33(10):1209-10. doi: 10.1016/j.ejso.2007.01.030. Epub 2007 Mar 12.

Authors

H Sørbye¹, B Westre, A Horn

Affiliation

¹ Department of Oncology, Haukeland University Hospital, Bergen, Norway. half@helse-bergen.no

PMID: 17350785
DOI: 10.1016/j.ejso.2007.01.030

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Carcinoma, Neuroendocrine / diagnostic imaging
Carcinoma, Neuroendocrine / pathology
Carcinoma, Neuroendocrine / secondary
Carcinoma, Neuroendocrine / therapy*
Cisplatin / administration & dosage
Etoposide / administration & dosage
Hepatectomy
Humans
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / pathology
Liver Neoplasms / secondary
Liver Neoplasms / therapy*
Male
Middle Aged
Neoadjuvant Therapy
Pancreas / diagnostic imaging
Remission Induction
Tomography, X-Ray Computed

Substances

Etoposide
Cisplatin